Figure EYE-5. Changes between 2001/02 and 2005/06 in prevalence of ever in lifetime cannabis use among school students aged 15–16

• Home
• Data

  Drug-related data at your fingertips

  Monitoring and analysing the nature and scale of the drugs phenomenon in Europe is a central part of the EMCDDA's work. The Statistical bulletin is published yearly by the EMCDDA and provides access to the most recent data on the drug situation in Europe. Access data »

  Data sets

  • General population surveys
  • Youth and the schools population
  • Problematic drug use population
  • Drug users in prison
  • Drug-related infectious diseases

  • Drug-related deaths and mortality
  • Treatment demand
  • Drug law offences
  • Health and social responses
  • Seizures data
  • Price and purity information
• Countries

  Drug-related information by country

  

  The countries section makes it easier than ever to find drug-related information and data by country. Each page brings together all of our available products by topic or format for the country in question. Go to the Countries section »

  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy

  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • Turkey
  • United Kingdom
• Topics (A–Z)

  New drugs and trends

  • Action on new drugs

  Health consequences

  • Deaths and mortality
  • Infectious diseases
  • Treatment demand

  Prevalence and epidemiology

  • General population surveys
  • Drug trends in youth
  • Problem drug use
  • Wastewater anaysis
  • Key indicators

  Drug-related thematic pages

  • Cannabis
  • Cocaine and crack
  • Opioids and heroin

  Drugs and society

  • Crime
  • Driving
  • Social exclusion
  • Women and gender issues
  • Young people

  Science and research

  • Neuroscience
  • Research in Europe

  Best practice

  • Best practice in prevention
  • Best practice in treatment
  • Best practice in harm reduction
  • Standards and guidelines
  • Exchange on Drug Demand Reduction Action (EDDRA)
  • Evaluation Instruments Bank (EIB)

  Health and social responses

  • Harm reduction
  • Prevention of drug use
  • Social reintegration
  • Treatment of drug use

  Policy and law

  • EU policy and law
  • Laws (ELDD)
  • Public expenditure

  Availability and supply

  • Diversion of chemical precursors
  • Money laundering activities
  • Supply reduction
  • Supply, markets and availability indicators

  Drug profiles

  Drug profiles are scientifically sound descriptions of drugs.

  • Amphetamine
  • Barbiturates
  • Benzodiazepines
  • BZP and other piperazines
  • Cannabis
  • Cocaine and crack
  • Fentanyl
  • Hallucinogenic mushrooms
  • Heroin
  • Khat
  • Kratom
  • LSD
  • MDMA
  • Methamphetamine
  • Salvia divinorum
  • Synthetic cannabinoids and 'Spice'
  • Synthetic cathinones
  • Synthetic cocaine derivatives
  • Volatile substances

  See all topics »

• Publications

  Publications database

  

  Our publications are tailored to the needs of specific audiences and published in a variety of print or web formats. Access the Publications database.

  Search

  in title in summary or chapter titles

  List all publications

  by title | by date

  Year of publication

  2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 

  Series/type

  Annual report | Drugnet Europe | Drug policy profiles | Drugs in focus | Implementation reports | Insights | Joint publications | Joint reports | Literature reviews | Manuals | Monographs | National reports | Risk assessments | Selected issues | Technical data sheets | Thematic papers
  

  Documents about the EMCDDA

  Annual accounts | Brochures | Budget | General report of activities | Work programmes

  Annual report: the state of the drugs problem in Europe
  

  The annual report on the state of the drugs problem in Europe presents the EMCDDA's yearly overview of the drug phenomenon. This is an essential reference book for policymakers, specialists and practitioners in the drugs field. It is available for download in PDF in 22 languages or can be accessed as an online publication (English only).

  All publications »

• News and events

  News and events

  • Latest news
  • News archive
  • Newsletter
  • Events
  • Press room

  Media support

  To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations unit:
  
  Kathy Robertson
  Head of sector
  Media relations and marketing
  Tel: (351) 211 21 02 00/32
  Fax: (351) 21 813 1711
  
  Maria José Louro
  Media relations assistant
  Tel: (351) 211 21 02 00/40
  Fax: (351) 21 813 1711
  

  Follow us

  • Twitter
  • Facebook
  • Flickr
  • YouTube
  • RSS
  • Newsletter
• About the EMCDDA

  About the EMCDDA

  Mission
  The EMCDDA was set up to provide 'factual, objective, reliable and comparable information concerning drugs, drug addiction and their consequences' »

  Organisation
  Information about the EMCDDA's organisational structure and its statutory bodies »

  Partners
  Cooperation with EU institutions, the Reitox network and regional and international organisations has been an important part of the EMCDDA’s work since its creation in 1993 »

  Job vacancies
  Details on current vacancies and the status of ongoing recruitments »

  Procurement The EMCDDA works with a variety of external contractors. Its needs for external services are announced through a call for tender »

  

  Contact us
  European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
  Cais do Sodré
  1249-289 Lisbon
  Portugal
  Tel. (351) 211 21 02 00

  Quick links (A-Z)

  calls for tender | EMCDDA Director | EMCDDA units | founding regulation | Management Board | national focal points | partners | Scientific Committee | staff list | vacancies

Page last updated: Monday, 28 July 2008